Author/Editor | Eikelboom, John W.; Kozek-Langenecker, S.; Exadaktylos, A.; Batorova, A.; Boda, Z.; Christory, F.; Gornik, I.; Kekstas, Gintautas; Kher, André; Komadina, Radko | |
Title | Emergency care of patients receiving non-vitamin K antagonist oral antocoagulants | |
Type | članek | |
Vol. and No. | Letnik 120, št. 4 | |
Publication year | 2018 | |
Volume | str. 645-656 | |
ISSN | 0007-0912 - British Journal of Anaesthesia | |
Language | eng | |
Abstract | Non-vitamin K antagonist oral anticoagulants (NOACs), which inhibit thrombin (dabigatran) and factor Xa (rivaroxaban, apixaban, edoxaban) have been introduced in several clinical indications. Although NOACs have a favourable benefit-risk profile and can be used without routine laboratory monitoring, they are associated - as any anticoagulant - with a risk of bleeding. In addition, treatment may need to be interrupted in patients who need surgery or other procedures. The objective of this article, developed by a multidisciplinary panel of experts in thrombosis and haemostasis, is to provide an update on the management of NOAC-treated patients who experience a bleeding episode or require an urgent procedure. Recent advances in the development of targeted reversal agents are expected to help streamline the management of NOAC-treated patients in whom rapid reversal of anticoagulation is required. | |
Descriptors | Anticoagulants Hemorrhage Hemorrhage Antikoagulanti Krvavitve Krvavitve Adverse effects Chemically induced Therapy Škodljivi učinki Kemično inducirane Zdravljenje |